Cited by 91Bone fractures and treatmentsBone Metabolism and DiseasesAngiogenesis and VEGF in Cancer

TNFα contributes to diabetes impaired angiogenesis in fracture healing

Open access
Lim, Jason C., Ko, Kang I., Mattos, Marcelo, Fang, Miao, Zhang, Citong, Feinberg, Daniel, Sindi, Hisham, Li, Shuai +5 more·2017·Bone

Abstract

Diabetes increases the likelihood of fracture, interferes with fracture healing and impairs angiogenesis. The latter may be significant due to the critical nature of angiogenesis in fracture healing. Although it is known that diabetes interferes with angiogenesis the mechanisms remain poorly defined. We examined fracture healing in normoglycemic and streptozotocin-induced diabetic mice and quantified the degree of angiogenesis with antibodies to three different vascular markers, CD34, CD31 and Factor VIII. The role of diabetes-enhanced inflammation was investigated by treatment of the TNFα-specific inhibitor, pegsunercept starting 10days after induction of fractures. Diabetes decreased both angiogenesis and VEGFA expression by chondrocytes. The reduced angiogenesis and VEGFA expression in diabetic fractures was rescued by specific inhibition of TNF in vivo. In addition, the TNF inhibitor rescued the negative effect of diabetes on endothelial cell proliferation and endothelial cell apoptosis. The effect of TNFα in vitro was enhanced by high glucose and an advanced glycation endproduct to impair microvascular endothelial cell proliferation and tube formation and to stimulate apoptosis. The effect of TNF, high glucose and an AGE was mediated by the transcription factor FOXO1, which increased expression of p21 and caspase-3. These studies indicate that inflammation plays a major role in diabetes-impaired angiogenesis in endochondral bone formation through its effect on microvascular endothelial cells and FOXO1.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.bone.2017.02.014

Cites

36 of 36 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Aging leads to increased long-term expression of TNF-α, which delays early inflammation and cartilage formation in fracture healing and decreases overall VEGF, affecting angiogenesis and bone healing.

    “aging leads to increased long-term expression of TNF-α, which leads to delayed early inflammation and cartilage formation processes in fracture healing and a decrease in overall VEGF, which affects angiogenesis to the point of affecting bone healing”

    From Modulation of fracture healing by senescence-associated secretory phenotype (SASP): a narrative review of the current literature (2024) · cites this paper as [90]

    The Introduction and Discussion (page numbers not supplied) link prolonged TNFα expression in diabetic fractures to reduced VEGFA expression and impaired angiogenesis. They do not establish aging as the cause, and they describe early inflammation as beneficial rather than delayed; the Introduction describes early cartilage resorption, not delayed cartilage formation. (LLM, conf=0.88)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 1

  1. [37]Kayal RA Siqueira M Alblowi J McLean J Krothapalli N Faibish D Einhorn TA Gerstenfeld LC Graves DT TNF-α mediates diabetes-enhanced chondrocyte apoptosis during fracture healing and stimulates chondrocyte apoptosis through FOXO1 Journal of Bone and Mineral Research 25 7 2010 1604 1615 20200974 PMC3154002

Cited by

Sorted by citations

Authors
Lim, J. C., Ko, K. I., Mattos, M., Fang, M., Zhang, C., Feinberg, D., Sindi, H., Li, S., Alblowi, J., Kayal, R. A., Einhorn, T. A., Gerstenfeld, L. C., & Graves, D. T.
Affiliations
  • University of Pennsylvania (US)
  • Shanxi Provincial People’s Hospital (CN)
  • Jilin University (CN)
  • Peking University (CN)
  • King Abdulaziz University (SA)
  • Boston University (US)
Corresponding author
Graves, Dana T.
Venue
Bone
Publisher
Elsevier BV
Published
2017-06
Volume
99
Pages
26-38
ISSN
  • 1873-2763 (ISSN-L)
  • 8756-3282
OpenAlex
W2591689403
Cited by
91
References
36
Citations by year
2026: 16 · 2025: 7 · 2024: 6 · 2023: 7 · 2022: 10 · 2021: 12 · 2020: 15 · 2019: 8 · 2018: 6 · 2017: 4
FWCI
7.07
Type
journal article
Language
en
Open access
Locations
  • Bone (publishedVersion)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
  • ScholarlyCommons (University of Pennsylvania) (submittedVersion, cc-by-nc-nd)
Funders
NIH (AR060055, DE019108)
Topics
  • Health Sciences › Medicine › Epidemiology › Bone fractures and treatments
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bone Metabolism and Diseases
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
Keywords
TNF-α, diabetes mellitus, fracture healing, angiogenesis, VEGF-A, chondrocytes, endothelial cell proliferation, endothelial cell apoptosis, FOXO1, advanced glycation end products, high glucose, inflammation, p21, caspase-3, endochondral ossification, microvascular endothelial cells, streptozotocin-induced diabetes
MeSH terms
Animals, Diabetes Mellitus, Experimental, Factor VIII, Hyperglycemia, Inflammation, Male, Polyethylene Glycols, Tumor Necrosis Factor-alpha, Fracture Healing, Antigens, CD34, Platelet Endothelial Cell Adhesion Molecule-1, Vascular Endothelial Growth Factor A, Receptors, Tumor Necrosis Factor, Type I, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review